Related Experiment Videos
Muscular adaptations to resistance exercise in the elderly
M V Narici1, N D Reeves, C I Morse
1Institute for Biophysical and Clinical Research into Human Movement, Manchester Metropolitan University, Alsager, Cheshire, UK. m.narici@mmu.ac.uk
Journal of Musculoskeletal & Neuronal Interactions
|December 24, 2004
Summary
Sarcopenia, an age-related muscle loss, causes weakness due to reduced muscle size and altered architecture. Resistance training can reverse these age-related muscle changes and improve strength.
Area of Science:
- Gerontology and Muscle Physiology
Background:
- Sarcopenia, the age-related loss of muscle mass, leads to muscle weakness.
- Muscle strength decline in sarcopenia often surpasses muscle size reduction.
- Factors contributing to sarcopenia include neuropathic, metabolic, hormonal, nutritional, and immunological aspects.
Purpose of the Study:
- To investigate the contributing factors and mechanisms behind sarcopenia.
- To understand the relationship between muscle size, architecture, and strength loss in aging.
- To explore the potential for reversing age-related muscle alterations through exercise.
Main Methods:
- Review of current evidence on sarcopenia development and progression.
- Analysis of studies examining neural drive, fiber specific tension, and muscle architecture.
- Evaluation of the effects of resistive training on muscle hypertrophy and architecture in older adults.
Main Results:
- Ageing alters muscle architecture and reduces neural drive, contributing to decreased muscle force.
- Muscle strength loss is disproportionately greater than muscle mass loss in sarcopenia.
- Resistive training demonstrates significant muscle hypertrophy and reverses age-related architectural changes in older muscle.
Conclusions:
- Sarcopenia involves complex multifactorial causes and significant changes in muscle mechanics.
- Muscle architecture alterations play a crucial role in age-related force reduction.
- Older muscle retains plasticity, with resistive training effectively combating sarcopenia's effects.